Delivery Order SPE2DB22D3004-SPE2DB25FPC10

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,757.54 firm fixed-price delivery order is for the supply of 4563846545 MODAFINIL 200 MG TABLET 30S. The contract has an ultimate completion date of March 5, 2024 and was awarded on March 4, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,597.18 firm fixed-price delivery order is for the supply of 4567456991 - MODAFINIL 100 MG TABLET 30S, with a period of performance through March 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, with ID SPE2DB20D1109|SPE2DB24FP35M, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,922.40 firm fixed-price delivery order is for the supply of 4564931849 - MODAFINIL 200 MG TABLET 30S, with a completion date of June 18, 2024. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,999.01 Firm Fixed Price Delivery Order contract is for the supply of 4567421591 Modafinil 100 mg Tablets, a medication used to treat conditions like sleep disorders. The contract has an ultimate completion date of March 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,372.35 firm fixed-price delivery order contract is for the supply of 4,567,314,580 units of the drug Modafinil 100 mg tablets. The contract has an ultimate completion date of February 20, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,398.65 Firm Fixed Price Delivery Order is for the supply of 4567461586 - MODAFINIL 100 MG TABLET 30S, with a completion date of March 5, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,249.84 firm fixed-price delivery order is for the supply of 4564558923 MODAFINIL 200 MG TABLET 30S. The contract has an ultimate completion date of May 10, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FAKX9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,050.28 firm fixed-price delivery order is for the supply of 4567011579 ! MODAFINIL 200 MG TABLET 30S. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX9RU, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,358.26, is for the delivery of 4567175381 MODAFINIL 100 MG TABLET 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 6, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEAM8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,156.76, is a delivery order for 4,567,394,713 units of the prescription medication Modafinil 100 mg tablets. The contract has a firm fixed price and an ultimate completion date of February 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPC10
    Delivery Order

This federal contract award, with identifier SPE2DB22D3004|SPE2DB25FPC10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,134.42 firm fixed-price delivery order is for the supply of MODAFINIL 200 MG TABLET 30S, a pharmaceutical product, with a completion date of January 15, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 5/21/25, 10:05 AM